期刊文献+

度洛西汀联合氟比洛芬巴布膏用于非特异性肋软骨炎患者的观察

Observation of Duloxetine Combined with Flurbiprofen Cataplasms in Patients with Nonspecific Costochondritis
下载PDF
导出
摘要 目的观察度洛西汀联合氟比洛芬巴布膏治疗非特异性肋软骨炎的疗效。方法选取非特异性肋软骨炎患者120例,按随机数字表法分为A、B两组,每组60例。A组联合应用度洛西汀和氟比洛芬巴布膏;B组单独使用氟比洛芬巴布膏。于治疗前和治疗后1、3、7d由专业医师在双盲条件下采用视觉模拟评分法(VAS)对两组患者进行疼痛程度评分,并于治疗7d后对两组行疗效评定。结果治疗后1、3、7d,两组患者的VAS评分与组内治疗前比较,差异均有统计学意义(P<0.05)。治疗后,A组患者痊愈40例(66.7%),显效8例(20%),好转2例(3.3%),痊愈率显著高于B组,差异均有统计学意义(P<0.05)。结论度洛西汀联合氟比洛芬巴布膏可较快缓解非特异性肋软骨炎患者的疼痛症状,短期治愈率高。 Objective To observe the efficacy of duloxetine combined with Flurbiprofen Cataplasms in the treatment of nonspecific costochondritis.Methods One hundred and twenty patients with nonspecific costal chondritis were selected and divided into group A and group B equally,which is 60 patients in each.Group A was combined with duloxetine and Flurbiprofen cataplasms,while group B was treated with Flurbiprofen cataplasms only.Before treatment and on 1,3,7 days after treatment,visual analogue scale(VAS)was used to score the pain degree of the two groups of patients by a professional physician in the double-blind condition,and evaluated the efficacy of two groups 7 days after treatment.Results After treatment 1,3,and 7 days,the VAS scores of two groups were significantly different from those before treatment in groups(P<0.05).After treatment,40 cases(66.7%)of patients in group A were cured,8 cases(20%)were markedly improved,and 2 cases(3.3%)were improved.The cure rate was significantly higher than that in group B,and the differences were statistically significant(P<0.05).Conclusion Duloxetine combined with Flurbiprofen cataplasms can relieve pain symptoms of patients with non-specific costochondritis quickly,and the short-term cure rate is high.
作者 魏国华 王娟 WEI Guo-hua;WANG Juan(Department of Anesthesiology,The First Affiliated Hospital of Nanjing Medical University,Nanjing Jiangsu,210029,China)
出处 《承德医学院学报》 2021年第2期113-115,共3页 Journal of Chengde Medical University
关键词 度洛西汀 氟比洛芬巴布膏 非特异性肋软骨炎 duloxetine flurbiprofen cataplasms nonspecific costochondritis
  • 相关文献

参考文献7

二级参考文献68

  • 1方忠,李锋,熊伟,李光辉,敦先礼.特异性COX-2抑制剂保护骨关节炎软骨的临床观察[J].实用骨科杂志,2006,12(1):29-32. 被引量:10
  • 2季元清,崔洪章.曲安奈德局部封闭治疗非特异性肋软骨炎258例[J].中国冶金工业医学杂志,2006,23(3):428-428. 被引量:3
  • 3Miyamoto T, Ogino N, Y amamoto S, et al. Purific- ation of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem, 1976, 251 : 2629 - 2636,.
  • 4Xie WL, Chipman JG, Roberts on DL, et al. Expre- ssion of a mitogen 2 responsive gene encoding prostaglandin synthase is regulated by mRNA spli- cing. Proc Natl Acad Sci, 1991, 88:2692- 2696.
  • 5Chandrasekharan NV, Dai H, Roos KL, et al. COX- 3, a cyclooxygenase-1 variant inhibited by acetam- inophen and other analgesic/antipyretic dru-gs: cl- oning, structure, and expression. Proc Natl Acad Sci, 2002, 99: 13926- 13931.
  • 6Steinmeyer J. Pharmacological basis for the thera- py of pain and inflammation with nonsteroidal anti- inflammatory drugs. Arthritis Res, 2000, 2 : 379 385.
  • 7Morita I, Schindler M, Regier MK, et al. Different intracellular locations for prostaglandin endoperox ide H synthase-1 and-2. J Biol Chem, 1995, 270 : 10902- 10908.
  • 8Kis B, Snipes JA, Isse T, et al. Putative cyclooxyg- enase-3 expression in rat brain cells. J Ceerb Blood Flow Metba, 2003, 23 : 1287 - 1292.
  • 9Berenbaum F. COX-3: fact or fancy? Joint Bone Spine, 2004, 71 : 451 -453.
  • 10Sehwab JM, Beiter T, Linder JU, et al. COX-3 a virtual pain target in humans? FASEB J, 2003, 17 : 2174 - 2175.

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部